Pulmonary hypertension is a common complication of systemic sclerosis and generally portends a very poor prognosis. Response to modern therapy for scleroderma-related pulmonary arterial ...

Results The task force agreed on 22 recommendations covering 8 clinical/organ domains including Raynaud’s phenomenon, digital ulcers, pulmonary arterial hypertension, scleroderma renal crisis, skin ...

If you have scleroderma, it can take time to get the diagnosis. Scleroderma is rare, and the signs and symptoms are similar to many other diseases. Doctors who most commonly diagnose scleroderma are ...

Scleroderma is rare. The Scleroderma Foundation estimates that about 300,000 people in the United States have some type of scleroderma. The following explains who has a higher risk of developing ...

Pulmonary function tests (PFTs), including evaluation of forced vital capacity ... Despite being retrospective, our work aims to analyse the disease in its complexity, also considering the possible ...

Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol. 2015;67(12 ...

Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation and fibrosis of the skin that, especially in the pediatric population, also affects extracutaneous tissues ...

Pulmonary arterial hypertension (PAH ... For instance, Black people have a higher risk of getting scleroderma, getting it at a younger age, and having a more aggressive version of the disease.